Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u prethodnih 30 dana:5
  • preuzimanja u prethodnih 30 dana:5
članak: 1 od 1  
Back povratak na rezultate
Vojnosanitetski pregled
2015, vol. 72, br. 4, str. 361-367
jezik rada: engleski
vrsta rada: pregledni članak
doi:10.2298/vsp1504361p


Primena gvožđa u lečenju anemije bubrežnog porekla
Department of Urology and Nephrology, Clinical Center Kragujevac, Kragujevac + Faculty of Medical Sciences, Kragujevac

e-adresa: mileta.poskurica@gmail.com

Sažetak

Članak ne sadrži sažetak.

Ključne reči

Reference

*** (2007) KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. American journal of kidney diseases, 50(3): 471-530
*** (2006) II. Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in Adults. American Journal of Kidney Diseases, 47: S16
*** (2012) KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Suppl, 2(4); 279-335
Beutler, E., Waalen, J. (2006) The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?. Blood, 107(5): 1747-50
Crichton, R.R., Danielson, G.B., Geisser, P. (2008) Iron therapy-with special emphasis on intravenous administration. Bremen: Uni-Med Verlag, 4th ed
de Benoist, B., Mclean, E., Egli, I., Cogswell, M. (2008) Worldwide preva-lence of anaemia 1993-2005. WHO global database on anae-mia. Geneva: WHO
de Francisco, A.L. (2010) Individualizing anaemia therapy. Nephrol Dial Transplant Plus, 3(6); 519-26
Hörl, W.H. (2007) Clinical aspects of iron use in the anemia of kidney disease. Journal of the American Society of Nephrology, 18(2): 382-93
Jaćović, S., Petrović, D., Nikolić, A., Miloradović, V., Poskurica, M. (2013) Cardio-renal anemia syndrome: Etiopathogenesis, clinical significance and treatment. PONS - medicinski časopis, vol. 10, br. 2, str. 64-69
Locatelli, F., Aljama, P., Barany, P., Canaud, B., Carrera, F., i dr. (2004) Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant, 19 Suppl 2: ii1-47
Locatelli, F., Covic, A., Eckardt, K., Wiecek, A., Vanholder, R. (2009) Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrology, dialysis, transplantation, 24(2): 348-54
Macdougall, I.C., Ashenden, M. (2009) Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications. Advances in chronic kidney disease, 16(2): 117-30
Mix, T.H., Brenner, R.M., Cooper, M.E., de Zeeuw, D., Ivanovich, P., Levey, A.S., McGill, J.B., McMurray, J.J.V., Parfrey, P.S., Parving, H., Pereira, B.J.G., Remuzzi, G., Singh, A.K. (2005) Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. American heart journal, 149(3): 408-13
Nemet, D., Bogdanić, V., Labar, B., Jakšić, B. (2008) Erythrocyte disease in: Hematopoietic system and malignant tumors. u: Vrhovac B., Francetić I., Jakšić B., Labar B., Vucelić B. [ur.] Internal medicine, Zagreb: Naklada Ljevak, p. 931−51. (Serbian)
O`Mara, N.B. (2008) Anemia in Patients With Chronic Kidney Disease. Diabetes Spectrum, 21(1): 12-19
Palmer, S.C., Navaneethan, S.D., Craig, J.C., Johnson, D.W., Tonelli, M., Garg, A.X., Pellegrini, F., Ravani, P., Jardine, M., Perkovic, V., Graziano, G., McGee, R., Nicolucci, A. (2010) Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Annals of internal medicine, 153(1): 23-33
Pasricha, S.S., Flecknoe-Brown, S.C., Allen, K.J., Gibson, P.R., McMahon, L.P., Olynyk, J.K., Roger, S.D., Savoia, H.F., Tampi, R., Thomson, A.R., Wood, E.M., Robinson, K.L. (2010) Diagnosis and management of iron deficiency anaemia: a clinical update. Medical journal of Australia, 193(9): 525-32
Petrović, D., Milovanović, D., Miloradović, V., Nikolić, A., Petrović, M., Đurđević, P., Poskurica, M. (2012) Cardio-renal syndrome type 2: Etiopathogenesis, diagnosis and therapy. Medicinski časopis, vol. 46, br. 1, str. 30-34
Petrović, D., Jagić, N., Miloradović, V., Nikolić, A., Stojimirović, B. (2010) Cardio-renal syndrome: Definition, classification and basic principles of therapy. Serbian Journal of Experimental and Clinical Research, vol. 11, br. 2, str. 67-71
Petrović, D., Poskurica, M., Stojimirović, B. (2011) Left ventricular hypertrophy in hemodialysis patients: Risk factors and therapy. Medicinska istraživanja, vol. 45, br. 3, str. 30-35
Poskurica, M. (1998) Etiopathogenesis and incidence of cardiovascular disease in terminal renal failure. Leskovac: School of Dialysis, Leskovac, 98: Novelties in Nephrology, 1998; (1): 1−15. (Serbian)
Poskurica, M. (2012) Congestive heart failure in patients with impaired renal function. u: 2nd Serbian Congress of Nephrology, Belgrade; October 11−14, Belgrade: Collection of Abstracts, p. 13. (Serbian)
Poskurica, M. (1998) Terminal chronic renal insufficiency and associ-ated cardiovascular complications. Belgrade: Faculty of Medicine, [subspecialization]
Radonjić, V., Đurović, D., Đukić, Lj., ur. (2012) National Drug Register - NDR 2012. Belgrade: Medicines and Medical Devices Agency of Serbia, National Centre for Information on Medicines and Medical Devices
Remuzzi, G., Schiepanti, A., Minetti, L. (2004) Hematology cosequences of renal failure. u: Brener M.B., Rector F.C. [ur.] The Kidney, Philadelphia: Saunders, 7th ed. p. 2165-88
Schaefer, L., Schaefer, R.M. (2007) A primer on iron therapy. Nephrology, dialysis, transplantation, 22(9): 2429-31
Sharp, P., Srai, S. (2007) Molecular mechanisms involved in intestinal iron absorption. World journal of gastroenterology, 13(35): 4716-24
Swinkels, D.W., Wetzels, J.F.M. (2008) Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?. Nephrology, dialysis, transplantation, 23(8): 2450-3
Yamanishi, H., Iyama, S., Yamaguchi, Y., Kanakura, Y., Iwatani, Y. (2003) Total iron-binding capacity calculated from serum transferrin concentration or serum iron concentration and unsaturated iron-binding capacity. Clin Chem, 49(1): 175-8
Zoccali, C., Abramowicz, D., Cannata-Andia, J.B., Cochat, P., Covic, A., Eckardt, K., Fouque, D., Heimburger, O., McLeod, A., Lindley, E., Locatelli, F., Spasovski, G., Tattersall, J., Van, B.W. (2008) European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). Nephrology, dialysis, transplantation, 23(7): 2162-6